Clinical Trial Update: A Study to Evaluate FK778 in Kidney Transplant Patients [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 study evaluating FK778 in kidney transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• FK778

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation, Renal Transplantation | Phase 2 | Status: COMPLETED